Protagenic Therapeutics (PTIX)
Official siteBIOTECHNOLOGY
Last updated: Nov 16, 2026 at 4:00 PM ET
Protagenic Therapeutics (PTIX) Stock Chart
Protagenic Therapeutics (PTIX) closed at $0.45 on Nov 16, 2026. Its price fell 78.6% over the past 12 months. The month-end price fell 99.9% since Dec 2016, a compound annual decline of 48.5%.
Price Chart
From Dec 2016 to Oct 2026, its highest month-end close was $433.17 in Dec 2016 and its lowest $0.18 in Jul 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart PTIX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PTIX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 25.0%, and over 6 months it fell 30.8%. The month-end price fell 94.1% over the 3 years through Oct 2026, a compound annual decline of 61.2%.
| Period | Change |
|---|---|
| 1 month | -40.0% |
| 3 months | +25.0% |
| 6 months | -30.8% |
| 12 months | -78.6% |
| 12 months, with dividends | -78.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -94.1% | -61.2% |
| 5 years | -99.4% | -64.0% |
| Since Dec 2016 | -99.9% | -48.5% |
Price by Year
Its best calendar year was 2021, when the price rose 31.9%, and its weakest was 2025, when it fell 81.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.64 | -50.9% |
| 2025 | $1.30 | -81.1% |
| 2024 | $6.86 | -50.5% |
| 2023 | $13.87 | -38.1% |
| 2022 | $22.41 | -71.1% |
| 2021 | $77.59 | +31.9% |
| 2020 | $58.82 | -25.5% |
| 2019 | $79.00 | -29.5% |
| 2018 | $112.04 | -9.1% |
| 2017 | $123.25 | -71.5% |
Trading Range
The price is 38.5% below its 50-day average of $0.73 and 21.1% below its 200-day average of $0.57.
| Measure | Value | Price vs |
|---|---|---|
| Close (Nov 16, 2026) | $0.45 | |
| 50-day average | $0.73 | -38.5% |
| 200-day average | $0.57 | -21.1% |
Price Risk
Over 3 years, its largest fall from a peak was 99.5%.
| Measure | Value |
|---|---|
| 1-year beta | 0.65 |
| Largest fall, 1 year | -94.4% |
| Largest fall, 3 years | -99.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About PTIX
What is PTIX's 1-year price change?
Protagenic Therapeutics's price fell 78.6% over the past 12 months. With dividends included, the 12-month total return was -78.6%.
What is PTIX's 5-year price change?
Protagenic Therapeutics's month-end price fell 99.4% over the 5 years through Oct 2026, a compound annual decline of 64.0%. These figures leave out dividends.
What is PTIX's beta?
Protagenic Therapeutics's 1-year beta against the S&P 500 is 0.65, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 94.4%.
Is the PTIX chart free?
Yes. Advanced Charting for PTIX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
PTIX pages: Overview, Charting, Financials